Global Medical Cannabis Market, by Neurological Health Management, 2018-2027

Growth Outlook

• The 2027 portion of the Global Medical Cannabis Market, by Neurological Health Management, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 9846 Mn in 2026 and is projected to reach USD 11398 Mn by 2027 — a gain of about 16% over the forecast period, translating to a CAGR in the double digits.
• The global medical cannabis market has seen a significant rise in demand in recent years, especially in the field of neurological health management. Medical cannabis, also known as medical marijuana, refers to the use of the marijuana plant or its chemical extracts for medical purposes.
• What the regional split looks like (2026): Americas leads, holding roughly 73% of segment value — the single largest regional share. Europe is the second-largest contributor. Asia-Pacific and Middle East & Africa make up the remainder, in descending order.
• By 2027, Americas alone is expected to reach USD 8032 Mn, with Europe at USD 2497 Mn.

Market Dynamics

The global medical cannabis market has seen a significant rise in demand in recent years, especially in the field of neurological health management. Medical cannabis, also known as medical marijuana, refers to the use of the marijuana plant or its chemical extracts for medical purposes. It has shown remarkable potential in treating various neurological disorders and conditions, making it a popular option for patients and healthcare professionals alike. One of the main reasons for the growing demand for medical cannabis in neurological health management is its effectiveness in treating symptoms of conditions like epilepsy, multiple sclerosis, and Parkinson's disease. Many patients have reported a significant reduction in seizures and tremors after using medical cannabis, leading to an improved quality of life. Moreover, it has shown promising results in managing chronic pain associated with neurological disorders, providing patients with much-needed relief and reducing their dependence on traditional painkillers. Medical cannabis's role in managing mental health conditions related to neurological disorders is another driving factor for its demand. Research has shown that medical cannabis can improve symptoms of anxiety and depression in patients with conditions like Alzheimer's disease and dementia.

It also has a calming effect on the brain, which can be beneficial for patients with conditions like autism and ADHD. The growing trend of incorporating alternative and natural treatments in healthcare has also contributed to the demand for medical cannabis. Patients and healthcare professionals are increasingly recognizing the potential benefits of medical cannabis over traditional medications, which often come with a host of adverse side effects. Medical cannabis, on the other hand, has a lower risk of side effects and can be a safer option for patients, especially those with neurological conditions that require long-term treatment. In addition to treating neurological conditions, medical cannabis is also being explored for its potential in preventing certain diseases. Studies have shown that the cannabinoids present in medical cannabis can have neuroprotective properties and may help reduce the risk of conditions like Alzheimer's and Parkinson's disease. Overall, the demand for medical cannabis in neurological health management is expected to continue to rise as further research and clinical trials are conducted.

With its potential to improve the quality of life for patients and offer a safer alternative to traditional medications, medical cannabis is likely to play a significant role in the future of neurological healthcare.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2024.